Global Meningococcal Group B Vaccine Market
As the global economy mends, the 2021 growth of Meningococcal Group B Vaccine will have significa ... Read More
As the global economy mends, the 2021 growth of Menomune-A/C/Y/W-135 will have significant change from previous year. According to our (LP Information) latest study, the global Menomune-A/C/Y/W-135 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Menomune-A/C/Y/W-135 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Menomune-A/C/Y/W-135 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Menomune-A/C/Y/W-135 market, reaching US$ million by the year 2028. As for the Europe Menomune-A/C/Y/W-135 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Menomune-A/C/Y/W-135 players cover Sanofi Pasteur, GSK, Hualan Bio, and ZFSW, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Menomune-A/C/Y/W-135 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oligosaccharide
Polysaccharide
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Public
Private
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Walvax
Changsheng
Kanghua Bio
As the global economy mends, the 2021 growth of Meningococcal Group B Vaccine will have significa ... Read More
As the global economy mends, the 2021 growth of Measles, Mumps, and Rubella Virus Vaccine will ha ... Read More
As the global economy mends, the 2021 growth of Japanese Encephalitis Virus Vaccine will have sig ... Read More
As the global economy mends, the 2021 growth of Cholera Vaccines Oral Live will have significant ... Read More